Oscotec to Participate in BIO USA, Seeking Global Partnerships for Next-Generation PipelinesAug 24, 2026
Youngshin Kwak, Head of Oscotec Research Institute: “We Will Compete with Anti-Resistance Cancer Therapy Within 3 Years” [BioUSA]Aug 24, 2026
